Theraclion SA (EPA: ALTHE)
France
· Delayed Price · Currency is EUR 0.341
-0.016 (-4.48%)
Dec 19, 2024, 2:47 PM CET
Theraclion Revenue
Theraclion had revenue of 441.64K EUR in the half year ending June 30, 2024, with 27.46% growth. This brings the company's revenue in the last twelve months to 1.28M, down -31.40% year-over-year. In the year 2023, Theraclion had annual revenue of 1.82M with 47.49% growth.
Revenue (ttm)
1.28M
Revenue Growth
-31.40%
P/S Ratio
n/a
Revenue / Employee
45.82K
Employees
29
Market Cap
15.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.82M | 586.77K | 47.49% |
| Dec 31, 2022 | 1.24M | -245.50K | -16.58% |
| Dec 31, 2021 | 1.48M | 736.95K | 99.05% |
| Dec 31, 2020 | 744.00K | -2.39M | -76.23% |
| Dec 31, 2019 | 3.13M | 1.19M | 61.42% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Eurofins Scientific SE | 6.72B |
| Ipsen S.A. | 3.44B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |